title: Fatty acids reduce heparin-releasable LPL activity in cultured cardiomyocytes from rat heart.
abstract: Varying glucose and fatty acid (FA) concentrations in the medium of cultured cardiomyocytes from adult rat hearts were tested for effects on lipoprotein lipase (LPL) activity. Glucose (5.5, 11, and 25 mM in the culture medium for 18-22 h) had no effect on either heparin-releasable LPL (HR-LPL) or on cellular LPL (C-LPL) activities. When cardiomyocytes were cultured overnight with 60 microM oleate, HR-LPL activity was reduced to 20% of control, with no change in C-LPL activity or total C-LPL mass. Similar results (HR-LPL and C-LPL activities) were obtained with 60 microM concentrations of palmitate and myristate; linoleate and eicosapentaenoate did reduce C-LPL activity, but the decrease in HR-LPL activity was much greater. Oxfenicine, an FA oxidation inhibitor, did not alter the inhibitory effect of 60 microM oleate on HR-LPL. Short-term incubations (1 and 3 h) of cultured cardiomyocytes with 60 microM oleate did not displace LPL into the medium. Immunodetectable LPL on the cell surface of oleate-treated cultured cardiomyocytes was increased compared with control cells, but heparin treatment released the same amount of LPL mass that had reduced catalytic activity.
authors.affiliation: Smooth Muscle Research Group, Faculty of Medicine, The University of Calgary, Alberta, Canada.
authors.forename: L G
authors.initials: LG
authors.lastname: Anderson
authors.forename: R
authors.initials: R
authors.lastname: Carroll
authors.forename: H S
authors.initials: HS
authors.lastname: Ewart
authors.forename: A
authors.initials: A
authors.lastname: Acharya
authors.forename: D L
authors.initials: DL
authors.lastname: Severson
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D002846:Chromatography, Affinity; D003470:Culture Media; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D006352:Heart Ventricles; D006493:Heparin / Q000494:pharmacology; D007700:Kinetics; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D019301:Oleic Acid / Q000378:metabolism / Q000494:pharmacology; D051381:Rats
chemical_list: D003470:Culture Media; D004791:Enzyme Inhibitors; D005230:Fatty Acids, Nonesterified; D019301:Oleic Acid; C023010:4-hydroxyphenylglycine; D006493:Heparin; D008071:Lipoprotein Lipase; D005947:Glucose; D005998:Glycine